| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| Borison - Diamond/ | 2026-03-20 03:57 | - | ||
| Business Policies/ | 2026-03-20 03:57 | - | ||
| Commercial - Sales/ | 2026-03-20 03:57 | - | ||
| Commercial Interfere..> | 2026-03-20 03:58 | - | ||
| Data Control/ | 2026-03-20 03:58 | - | ||
| Diabetes/ | 2026-03-20 03:59 | - | ||
| DocumentDescriptionT..> | 2026-03-20 03:59 | 293K | ||
| Dutch Submission/ | 2026-03-20 03:59 | - | ||
| Efficacy/ | 2026-03-20 03:59 | - | ||
| Japanese Label Change/ | 2026-03-20 03:59 | - | ||
| MDL Preemption Brief..> | 2026-03-20 03:59 | - | ||
| McFadden Relationships/ | 2026-03-20 03:59 | - | ||
| Megabrand/ | 2026-03-20 03:59 | - | ||
| Misc/ | 2026-03-20 04:00 | - | ||
| Off-label/ | 2026-03-20 04:01 | - | ||
| Pediatric/ | 2026-03-20 04:01 | - | ||
| Pooling - Dredging -..> | 2026-03-20 04:01 | - | ||
| Promotion - Weight N..> | 2026-03-20 04:01 | - | ||
| Reinstein/ | 2026-03-20 04:01 | - | ||
| Research Control/ | 2026-03-20 04:01 | - | ||
| Study 15/ | 2026-03-20 04:02 | - | ||
| Study 41/ | 2026-03-20 04:02 | - | ||
| Transparency - Conce..> | 2026-03-20 04:02 | - | ||
| Weight Gain/ | 2026-03-20 04:02 | - | ||
| _vti_cnf/ | 2026-03-20 04:02 | - | ||